Literature DB >> 8923429

Treatment of xanthelasma palpebrarum with the pulsed dye laser.

M P Schönermark1, C Raulin.   

Abstract

UNLABELLED: BACKGROUND OF
OBJECTIVE: Treatment of xanthelasma palpebrarum may prove difficult due to its delicate location at the periorbita and its sometimes extensive dimension. During recent years, carbon dioxide and argon lasers have been used with good results. However, local anesthesia is always required, and there is a concrete risk of scarring and pigmentation changes after the treatment. STUDY DESIGN/PATIENTS AND METHODS: In this case report, we describe for the first time the treatment of xanthelasmas with the pulsed dye laser.
RESULTS: This technique can be carried out without anesthesia and shows excellent cosmetic results.
CONCLUSION: We see the pulsed dye laser as a good alternative to the hitherto used other two laser types in the treatment of xanthelasma palpebrarum.

Entities:  

Mesh:

Year:  1996        PMID: 8923429     DOI: 10.1002/(SICI)1096-9101(1996)19:3<336::AID-LSM9>3.0.CO;2-T

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  4 in total

1.  Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum.

Authors:  Emel Basar; Halit Oguz; Hakan Ozdemir; Sehirbay Ozkan; Hasim Uslu
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

2.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

3.  Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.

Authors:  Mona Abdelkader; Shereen Ezzelregal Alashry
Journal:  Saudi J Ophthalmol       Date:  2014-11-20

4.  Nonconventional Use of Flash-Lamp Pulsed-Dye Laser in Dermatology.

Authors:  Steven Nisticò; Piero Campolmi; Silvia Moretti; Ester Del Duca; Nicola Bruscino; Rossana Conti; Andrea Bassi; Giovanni Cannarozzo
Journal:  Biomed Res Int       Date:  2016-08-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.